Interim analysis of a phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

被引：0

作者：

Luck, HJ

Thomssen, C

duBois, A

Lisboa, BW

Untch, M

Kuhnle, H

Konecny, G

Janicke, F

Meerpohl, HG

Lindner, C

Hecker, D

Diergarten, K

机构：

[1] TECH UNIV MUNICH,FRAUENKLIN,W-8000 MUNICH,GERMANY

[2] LUDWIG LEOPOLD UNIV,FRAUENKLIN,MUNICH,GERMANY

[3] UNIV MUNICH,MUNICH,GERMANY

[4] ST VINCENTIUS KRANKENHAUS,KARLSRUHE,GERMANY

[5] BRISTOL MYERS SQUIBB CO,MUNICH,GERMANY

来源：

SEMINARS IN ONCOLOGY | 1996年 / 23卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 36

页数：4

共 20 条

[1]

Amadori D, 1996, SEMIN ONCOL, V23, P19

[2]

BRUNBILLA C, 1986, CANC TREAT REP, V70, P261

[3]

DOMBERNOWSKI P, 1994, ANN M EUR SOC MED ON

[4]

GIANNI L, 1995, S NEW DIR ANT CHEM P

[5] PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER [J].

HOLMES, FA ;

WALTERS, RS ;

THERIAULT, RL ;

FORMAN, AD ;

NEWTON, LK ;

RABER, MN ;

BUZDAR, AU ;

FRYE, DK ;

HORTOBAGYI, GN .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) :1797-1805

[6]

HOLMES FA, 1992, P AN M AM SOC CLIN, V11, P60

[7] A COMPARATIVE-STUDY OF DOXORUBICIN AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER [J].

HORTOBAGYI, GN ;

YAP, HY ;

KAU, SW ;

FRASCHINI, G ;

EWER, MS ;

CHAWLA, SP ;

BENJAMIN, RS .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01) :57-62

[8] A PROSPECTIVE RANDOMIZED COMPARISON OF EPIRUBICIN AND DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER [J].

JAIN, KK ;

CASPER, ES ;

GELLER, NL ;

HAKES, TB ;

KAUFMAN, RJ ;

CURRIE, V ;

SCHWARTZ, W ;

CASSIDY, C ;

PETRONI, GR ;

YOUNG, CW ;

WITTES, RE .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) :818-826

[9]

KLAASSEN U, 1995, P AN M AM SOC CLIN, V14, P122

[10]

LAWTON PA, 1990, BRIT J CANCER, V61, P177

← 1 2 →